Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2023 Filed Mar 14, 2023 23:50 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 23,460 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018684 · doc4.xml · derivative · entry 5 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,460 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:50 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionCommon Stock | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018684 · doc4.xml · nonDerivative · entry 3 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:50 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionCommon Stock | 23,460 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018684 · doc4.xml · nonDerivative · entry 1 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:47 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 64,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018683 · doc4.xml · derivative · entry 6 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,666 Underlying: Common Stock · 64,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:47 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 107,525 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018683 · doc4.xml · derivative · entry 5 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 107,525 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:47 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionCommon Stock | 64,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018683 · doc4.xml · nonDerivative · entry 3 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,681,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:47 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionCommon Stock | 107,525 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018683 · doc4.xml · nonDerivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,654,159 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:43 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 21,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018681 · doc4.xml · derivative · entry 6 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,666 Underlying: Common Stock · 21,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:43 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 23,460 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018681 · doc4.xml · derivative · entry 5 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,460 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:43 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionCommon Stock | 21,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018681 · doc4.xml · nonDerivative · entry 3 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 443,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:43 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionCommon Stock | 23,460 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018681 · doc4.xml · nonDerivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:38 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018680 · doc4.xml · derivative · entry 6 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,666 Underlying: Common Stock · 16,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:38 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 23,460 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018680 · doc4.xml · derivative · entry 5 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,460 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:38 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionCommon Stock | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018680 · doc4.xml · nonDerivative · entry 3 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,267,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:38 UTC |
CORASH LAURENCE MChief Scientific Officer
|
Exercise / conversionCommon Stock | 23,460 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018680 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,260,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:34 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018677 · doc4.xml · derivative · entry 7 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,666 Underlying: Common Stock · 16,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:34 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 23,460 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018677 · doc4.xml · derivative · entry 6 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,460 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. F5 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:34 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionCommon Stock | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018677 · doc4.xml · nonDerivative · entry 3 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 363,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:34 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionCommon Stock | 23,460 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018677 · doc4.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:24 UTC |
Moore CarolSVP Reg. & Quality
|
GrantRestricted Stock Unit | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015792 · doc4.xml · nonDerivative · entry 1 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393,866 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2024, subject to the Reporting Person's continuous service to the Issuer through such vesting date. F2 · balance_after: Includes 4,598 shares purchased under Issuer's Employee Stock Purchase Plan on 02/28/23, respectively. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:21 UTC |
Jensen ChrystalChief Legal Officer
|
GrantRestricted Stock Unit | 160,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015783 · doc4.xml · nonDerivative · entry 1 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,871 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2024, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:19 UTC |
Jayaraman Vivek KChief Operating Officer
|
GrantRestricted Stock Unit | 240,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015772 · doc4.xml · nonDerivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 614,226 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2024, subject to the Reporting Person's continuous service to the Issuer through such vesting date. F2 · balance_after: Includes 4,812 shares purchased under Issuer's Employee Stock Purchase Plan on 02/28/23, respectively. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:17 UTC |
Greenman William MarinerDirector · President and CEO
|
GrantRestricted Stock Unit | 575,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015762 · doc4.xml · nonDerivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,546,634 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2024, subject to the Reporting Person's continuous service to the Issuer through such vesting date. F2 · balance_after: Includes 4,442 shares purchased under Issuer's Employee Stock Purchase Plan on 02/28/23, respectively. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:16 UTC |
Green Kevin DennisChief Financial Officer
|
GrantRestricted Stock Unit | 185,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015758 · doc4.xml · nonDerivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,999 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2024, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:14 UTC |
CORASH LAURENCE MChief Scientific Officer
|
GrantRestricted Stock Unit | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015748 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,236,716 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2024, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:13 UTC |
Benjamin Richard JChief Medical Officer
|
GrantRestricted Stock Unit | 160,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015736 · doc4.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,665 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2024, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| December 28, 2022 Filed Jan 3, 2023 23:40 UTC Amendment |
SCHULZE GAILDirector
|
Exercise / conversionOption (Right to Buy) · Derivative | 25,000 | Not disclosed Strike: $3.19 | Not disclosed |
DisclosureSEC source: 0001209191-23-000425 · doc4a.xml · derivative · entry 2 SCHULZE GAIL · CIK 0001023259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2023-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: The option became exercisable in 12 equal monthly installments after the grant date. Read SEC document |
| December 28, 2022 Filed Jan 3, 2023 23:40 UTC Amendment |
SCHULZE GAILDirector
|
Exercise / conversionCommon Stock | 25,000 | $3.19 | $79,750.00 |
DisclosureSEC source: 0001209191-23-000425 · doc4a.xml · nonDerivative · entry 1 SCHULZE GAIL · CIK 0001023259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 23:25 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionOption (Right to Buy) · Derivative | 12,500 | Not disclosed Strike: $3.19 | Not disclosed |
DisclosureSEC source: 0001209191-22-056776 · doc4.xml · derivative · entry 3 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2023-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not applicable. F2 · derivative.exercise_date: The option became exercisable in 12 equal monthly installments after the grant date. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 23:25 UTC |
Swisher Daniel N JRDirector
|
SaleCommon Stock | 12,500 | $3.91 | $48,875.00 |
DisclosureSEC source: 0001209191-22-056776 · doc4.xml · nonDerivative · entry 2 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,808 F1 · price: The sales occurred in multiple trades at prices ranging from $3.915 to $3.910. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 23:25 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionCommon Stock | 12,500 | $3.19 | $39,875.00 |
DisclosureSEC source: 0001209191-22-056776 · doc4.xml · nonDerivative · entry 1 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:11 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 10,000 | $5.18 | $51,800.00 |
DisclosureSEC source: 0001209191-22-046374 · doc4.xml · nonDerivative · entry 1 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,871 F1 · price: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 23:05 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 10,000 | $5.12 | $51,194.00 |
DisclosureSEC source: 0001209191-22-045495 · doc4.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,665 F1 · price: This transaction was executed pursuant to a 10b5-1 plan. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.07 to $5.17 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| July 01, 2022 Filed Jul 12, 2022 20:47 UTC |
Shan HuaDirector
|
GrantOption (Right to Buy) · Derivative | 58,074 | Not disclosed Strike: $5.48 | Not disclosed |
DisclosureSEC source: 0001209191-22-041941 · doc4.xml · derivative · entry 2 Shan Hua · CIK 0001937467 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,074 Underlying: Common Stock · 58,074 shares Expires 2032-06-30 F3 · price: Not applicable. F2 · derivative.exercise_date: The option grant vests in three equal annual installments beginning on anniversary of the transaction date. Read SEC document |
| July 01, 2022 Filed Jul 12, 2022 20:47 UTC |
Shan HuaDirector
|
GrantCommon Stock | 29,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-041941 · doc4.xml · nonDerivative · entry 1 Shan Hua · CIK 0001937467 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,886 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on anniversary of the transaction date, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:22 UTC |
Witney FrankDirector
|
GrantOption (Right to Buy) · Derivative | 39,866 | Not disclosed Strike: $4.84 | Not disclosed |
DisclosureSEC source: 0001209191-22-034214 · doc4.xml · derivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,866 Underlying: Common Stock · 39,866 shares Expires 2032-05-31 F3 · price: Not applicable. F2 · derivative.exercise_date: The option shall vest one year from the date of grant. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:22 UTC |
Witney FrankDirector
|
GrantCommon Stock | 20,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034214 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,059 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:19 UTC |
Swisher Daniel N JRDirector
|
GrantOption (Right to Buy) · Derivative | 39,866 | Not disclosed Strike: $4.84 | Not disclosed |
DisclosureSEC source: 0001209191-22-034210 · doc4.xml · derivative · entry 2 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,866 Underlying: Common Stock · 39,866 shares Expires 2032-05-31 F3 · price: Not applicable. F2 · derivative.exercise_date: The option shall vest one year from the date of grant. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:19 UTC |
Swisher Daniel N JRDirector
|
GrantCommon Stock | 20,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034210 · doc4.xml · nonDerivative · entry 1 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,808 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:17 UTC |
SCHULZE GAILDirector
|
GrantOption (Right to Buy) · Derivative | 39,866 | Not disclosed Strike: $4.84 | Not disclosed |
DisclosureSEC source: 0001209191-22-034209 · doc4.xml · derivative · entry 2 SCHULZE GAIL · CIK 0001023259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,866 Underlying: Common Stock · 39,866 shares Expires 2032-05-31 F3 · price: Not applicable. F2 · derivative.exercise_date: The option shall vest one year from the date of grant. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:17 UTC |
SCHULZE GAILDirector
|
GrantCommon Stock | 20,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034209 · doc4.xml · nonDerivative · entry 1 SCHULZE GAIL · CIK 0001023259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,570 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:14 UTC |
NACHTSHEIM JAMI KDirector
|
GrantOption (Right to Buy) · Derivative | 39,866 | Not disclosed Strike: $4.84 | Not disclosed |
DisclosureSEC source: 0001209191-22-034207 · doc4.xml · derivative · entry 2 NACHTSHEIM JAMI K · CIK 0001223017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,866 Underlying: Common Stock · 39,866 shares Expires 2032-05-31 F3 · price: Not applicable. F2 · derivative.exercise_date: The option shall vest one year from the date of grant. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:14 UTC |
NACHTSHEIM JAMI KDirector
|
GrantCommon Stock | 20,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034207 · doc4.xml · nonDerivative · entry 1 NACHTSHEIM JAMI K · CIK 0001223017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,362 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:12 UTC |
MOORE TIMOTHY L.Director
|
GrantOption (Right to Buy) · Derivative | 39,866 | Not disclosed Strike: $4.84 | Not disclosed |
DisclosureSEC source: 0001209191-22-034204 · doc4.xml · derivative · entry 2 MOORE TIMOTHY L. · CIK 0001669207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,866 Underlying: Common Stock · 39,866 shares Expires 2032-05-31 F3 · price: Not applicable. F2 · derivative.exercise_date: The option shall vest one year from the date of grant. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:12 UTC |
MOORE TIMOTHY L.Director
|
GrantCommon Stock | 20,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034204 · doc4.xml · nonDerivative · entry 1 MOORE TIMOTHY L. · CIK 0001669207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,073 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:08 UTC |
BJERKHOLT ERICDirector
|
GrantOption (Right to Buy) · Derivative | 39,866 | Not disclosed Strike: $4.84 | Not disclosed |
DisclosureSEC source: 0001209191-22-034203 · doc4.xml · derivative · entry 2 BJERKHOLT ERIC · CIK 0001197350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,866 Underlying: Common Stock · 39,866 shares Expires 2032-05-31 F3 · price: Not applicable. F2 · derivative.exercise_date: The option shall vest one year from the date of grant. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:08 UTC |
BJERKHOLT ERICDirector
|
GrantCommon Stock | 20,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034203 · doc4.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,133 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| May 10, 2022 Filed May 12, 2022 22:36 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 57,335 | $4.98 | $285,373.50 |
DisclosureSEC source: 0001209191-22-028638 · doc4.xml · nonDerivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,999 F1 · price: This transaction was executed pursuant to a 10b5-1 plan. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.77 to $5.28 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 02:00 UTC |
Greenman William MarinerDirector · President and CEO
|
SaleCommon Stock | 33,276 | $5.04 | $167,697.73 |
DisclosureSEC source: 0001209191-22-019066 · doc4.xml · nonDerivative · entry 6 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,967,192 F2 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 02:00 UTC |
Greenman William MarinerDirector · President and CEO
|
SaleCommon Stock | 53,702 | $5.04 | $270,631.23 |
DisclosureSEC source: 0001209191-22-019066 · doc4.xml · nonDerivative · entry 4 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,935,801 F2 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.